Development of a new screening system for drugs that modify the signaling pathways regulating the actin cytoskeleton
Development of a new screening system for drugs that modify the signaling pathways regulating the actin cytoskeleton
批准号:
11557008
负责人:
TANAKA Kazuma
金额:
$7.04万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abnormal regulation of the actin cytoskeleton is implicated in the invasion and metastasis of the cancer cells. The actin cytoskeleton system is conserved in the yeast Saccharomyces cerevisiae, suggesting that S.cerevisiae can be used to search for a new drug which prevents the invasion and metastasis of the cancer cells. However, there are still many things that remain to be studied. In this study, we have investigated the regulation of the actin cytoskeleton and attempted to establish such a system. (1) Isolation of the MTI1 gene as a regulator of the type I myosins. The yeast type I myosins, Myo3/5p, are involved in the reorganization of the actin cytoskeleton. The SH3 domain of Myo5p has been shown to interact with Las17p [a homolog mammalian Wiskott-Aldrich syndrome protein (WASP)] and Vrp1p [a homolog of WASP-interacting protein (WIP)] to regulate polymerization of actin. Vrp1p is required for the localization of Myo5p to cortical patch-like structures and for the ATP-independent … More interaction of the Myo5p tail region with actin filaments. We found that a new adaptor protein, Mti1p (Myosin tail region-interacting protein), interacts with the SH3 domains of Myo3/5p. Mti1p is coimmunoprecipitated with Myo5p and Mti1p-EGFP is colocalized with cortical actin patches. Although the mti1 null mutation did not cause any obvious phenotype by itself, it suppressed the phenotypes of the vrp1 mutants, including temperature-sensitive growth, abnormally large morphology, and endocytosis deficiency. Our results indicate that Mti1p and Vrp1p antagonistically regulate the functions of type I myosins. (2) Development of the screening system. Mammalian WASP, WIP, or type I myosins are being expressed in yeast. We are looking for a mammlian homolog of Mti1p. We will generate mutant genes that dominantly inhibit cell growth by affecting the reorganization of the actin cytoskeleton. Drugs that rescue growth inhibition of the yeast cells may interfere with the function of the mutant mammalian proteins. Less
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tanaka, K.: "Formin family proteins in cytoskeletal control"Biochem.Biophys.Res.Commun.. Vol 267. 479-481 (2000)
Tanaka, K.:“细胞骨架控制中的 Formin 家族蛋白”Biochem.Biophys.Res.Commun.. Vol 267. 479-481 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
田中一馬,高井義美: "岩波講座「現代医学の基礎」第2巻「分子細胞の生物学II-細胞」第5章「細胞内シグナル伝達機構」"岩波書店. 1-243 (2000)
田中和真、高井义美:《岩波讲座《现代医学基础》第2卷《分子细胞生物学II-细胞》第5章《细胞内信号转导机制》》岩波书店1-243(2000年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka, K.: "Formin family proteins in cytoskeletal control"Biochem.Biophys.Res.Commun.. 267. 479-481 (2000)
Tanaka, K.:“细胞骨架控制中的 Formin 家族蛋白”Biochem.Biophys.Res.Commun.. 267. 479-481 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujiwara, T., et al.: "The formin Bni1p regulates microtubule-dependent nuclear migration through the actin cytoskeleton in Saccharomyces cerevisiae"Mol.Cell.Biol. 19. 8016-8027 (1999)
Fujiwara, T., et al.:“formin Bni1p 通过酿酒酵母中的肌动蛋白细胞骨架调节微管依赖性核迁移”Mol.Cell.Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kikyo, M., Tanaka, K., Kamei, T., Ozaki, K., Fujiwara, T., Inoue, E., Takita, Y., Ohya, Y., and Takai, Y.: "An FH1 domain-containing Bnrlp is a multifunctional protein interacting with a variety of cytoskeletal proteins in Saccharomyces cerevisiae"Oncogen
Kikyo, M.、Tanaka, K.、Kamei, T.、Ozaki, K.、Fujiwara, T.、Inoue, E.、Takita, Y.、Ohya, Y. 和 Takai, Y.:“FH1 域
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Studies on cell functions regulated by changes in membrane phospholipid asymmetry
-
批准号:21370085
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2009
-
负责人:TANAKA Kazuma
-
依托单位:
Roles for phospholipid asymmetry in cell polarity
-
批准号:15370081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.62万
-
财政年份:2003
-
负责人:TANAKA Kazuma
-
依托单位:
Isolation and analysis of new genes that regulate the actin cytoskeleton system
-
批准号:11480205
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$7.49万
-
财政年份:1999
-
负责人:TANAKA Kazuma
-
依托单位:
Analysis of the Rho small GTP-binding proteinmediated signaling cascade
-
批准号:09680693
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1997
-
负责人:TANAKA Kazuma
-
依托单位:
Development of the screening system for a new drug which modifies the Rho small GTP-binding protein-mediated signaling pathway
-
批准号:09557011
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.02万
-
财政年份:1997
-
负责人:TANAKA Kazuma
-
依托单位:
海外基金